Drs Wallaert-Moerman
ActiveFrom the official registers: KBO 20 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
Drs Wallaert-Moerman has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €192,207 and a net result of €29,282, of which €150,000 non-recurring income. Equity has been growing by about 7.9% per year since 2019. Its solvency ranks better than 91% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 27-01-2005 Normal situation
- Activity
- Specialist medical practice NACE 86220
- Establishment unit
- 2.282.726.041 9830 Sint-Martens-Latem, since 27-01-2005
- Financial year end
- 30 June
- Peppol
- Reachable since 12-12-2025
Board and ownership
- MOERMAN MiekeDirector · since 01-01-2020
- WALLAERT Paul Cyriel AlfonsDirector · since 01-01-2020
Financial position
- Bankruptcy probabilitywithin 12 months
- < 0.1%
- Gross margin
- €108,733
- ▲ 53.5%
- Turnover
- ≈ €200,000
- estimated
- Profit
- €29,282
- ▲ 180×
- Equity
- €192,207
- ▲ 1.5%
- Total assets
- €202,476
- ▼ 12.2%
Score breakdownlowers riskLiquidity: current ratio 17.82, cash €147,868Sector: Human health activities (NACE 86)Equity €192,207 (94.9% of total assets)Size: total assets €202,476Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 39% on profitability and 41% on growth.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 4 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
Key points
Comparable companies
These companies have the same main activity as Drs Wallaert-Moerman: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €191,000 and €231,000, founded between 2002 and 2007.
| Company | Total assets | Gross margin |
|---|---|---|
| Drs Wallaert-Moerman Deinze | €202,476 | €108,733 |
| DOKTER FERRE GRIGNARD Zwalm | €222,140 | €111,832 |
| DR. DE BRAEKELEER KATRIEN PNEUMOLOGIE Enghien | €196,180 | €107,757 |
| VERWACHT QUENTIN Oudergem | €191,359 | €114,680 |
| CABINET MEDICAL PONCIN Namur | €198,089 | €113,021 |
| SOCIETE MEDICALE KARGAR Sint-Jans-Molenbeek | €230,926 | €103,005 |
| CHIREXPERT Waterloo | €218,441 | €122,676 |
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 28-01-2026
- Annual accounts 2024filed on 30-01-2025
- Annual accounts 2023filed on 25-01-2024
- Annual accounts 2022filed on 30-01-2023
Acts in the Belgian Official Gazette
- Registered office · Amendment of the articles · Legal-form change · Resignations & appointmentsact of 01-02-2024
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about Drs Wallaert-Moerman
- What is the company number of Drs Wallaert-Moerman?
- The company number of Drs Wallaert-Moerman is 0871.489.867. The VAT number is the same number with BE in front: BE 0871.489.867.
- Where is Drs Wallaert-Moerman based?
- The registered office is at Stokstormestraat 10, 9800 Deinze.Company details
- What does Drs Wallaert-Moerman do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of Drs Wallaert-Moerman?
- The legal form of Drs Wallaert-Moerman is Private limited company (BV).
- When was Drs Wallaert-Moerman founded?
- Drs Wallaert-Moerman was founded on 27-01-2005.
- Is Drs Wallaert-Moerman still active?
- Yes, Drs Wallaert-Moerman is an active enterprise in the KBO register.
- How many employees does Drs Wallaert-Moerman have?
- Drs Wallaert-Moerman had an average of 0.2 full-time equivalents in financial year 2019, according to the filed annual accounts.Financials
- What is the turnover of Drs Wallaert-Moerman?
- The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €108,733 and 43 comparable companies (NACE 86220). It probably lies between €170,000 and €270,000.
- Is Drs Wallaert-Moerman profitable?
- In financial year 2025, Drs Wallaert-Moerman made a profit of €29,282.
- Where can I find the annual accounts of Drs Wallaert-Moerman?
- Drs Wallaert-Moerman filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
- When are the next annual accounts of Drs Wallaert-Moerman due?
- Drs Wallaert-Moerman must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.